Status:

TERMINATED

A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Anemia

Chronic Kidney Disease

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

This study will evaluate the efficacy and safety of intravenous MK2578, given as maintenance treatment for renal anemia in chronic kidney disease patients on dialysis who were previously receiving ery...

Detailed Description

This study consists of a 12-week base study (MK2578-003-AM03) and an optional 40-week extension study (MK2578-003-EXT12). Participants who complete 12 weeks of treatment in the base study will enter t...

Eligibility Criteria

Inclusion

  • Base Study:
  • Patient is male or is a female who either cannot have children or who agrees to use appropriate contraceptive measures
  • Patient has been on hemodialysis for at least 6 months when informed consent is signed
  • Patient has received intravenous epoetin alfa or epoetin beta for a least 6 months when the informed consent is signed
  • Extension Study:
  • Patient completed the base study through Week 12
  • Patient tolerated MK2578 and demonstrated compliance with study procedures

Exclusion

  • Patient has a life expectancy of less than 6 months
  • Patient is scheduled for a kidney transplant within the next 6 months
  • Patient has had a blood transfusion within 12 weeks of screening
  • Patient has had major surgery within 12 weeks of screening or plans to have surgery
  • Patient has Human Immunodeficiency Virus (HIV)
  • Patient has history of blood dyscrasia, hematologic disorders or any other disease known to cause anemia
  • Patient has severe congestive heart failure (CHF)
  • Patient has a history of malignant cancer, except certain skin or cervical cancers
  • Patient has a history of grand mal seizures within the last 6 months

Key Trial Info

Start Date :

June 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT00924781

Start Date

June 1 2009

End Date

May 1 2010

Last Update

November 2 2015

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12) | DecenTrialz